<DOC>
	<DOCNO>NCT01635101</DOCNO>
	<brief_summary>The purpose study demonstrate efficacy safety Intravenous ( IV ) acetaminophen plus rescue opioids relief moderate severe acute pain neonate infant ( age &lt; 2 year ) compare placebo plus standard care rescue opioids well characterize concentration-effect relationship ( PK/PD ) intravenous acetaminophen compare control group .</brief_summary>
	<brief_title>A Multi-Center Study Efficacy , Pharmacokinetics ( PK ) Pharmacodynamics ( PD ) IV Acetaminophen Treatment Acute Pain Pediatric Patients</brief_title>
	<detailed_description />
	<mesh_term>Acute Pain</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Subject â‰¥ 28 week gestational age &lt; 2 year old study enrollment Subject undergo surgery traumatic injury expect produce moderate severe pain patient expect require analgesic treatment acute pain 24 hour Subject medically reasonable need IV treatment due underlying procedure ( ) medical condition ( ) duration study Subject reliable vascular access administration study medication PK sample Subject bodyweight , opinion Investigator preclude participation study . Subject free physical , mental , medical condition , opinion Investigator , make study participation inadvisable make impossible accurately assess efficacy safety endpoint Subject 's parent guardian must provide write informed consent prior participation study Subject 's parent guardian must ability read understand study procedure ability communicate meaningfully study investigator staff Subject able comply sample requirement study Subject know suspected hypersensitivity acetaminophen excipients IV acetaminophen Subject significant medical condition opinion Investigator contraindicate participation study impairs assessment efficacy safety ( example , neurologic disease hemiplegia , demyelinate disorder , neuromuscular paralysis , requirement prolong mechanical ventilation make impossible ass pain scale use LNPS FLACC ) Subject participate another interventional clinical study within 30 day plan study randomization date PreRandomization ( Qualification ) Inclusion Criteria Subject administer follow : acetaminophencontaining product , nonsteroidal antiinflammatory agent , central alphaadrenergic agent ( e.g. , clonidine , dexmedetomidine ) ketamine within 6 hour T0 receive regional neuraxial ( caudal , epidural spinal ) anesthetic local anesthetic within 6 hour T0 Subject abnormal LFTs sample obtain postoperatively/posttrauma prior randomization follow limit : TBL &gt; 3 time upper limit normal range age , OR ALT ( SGPT ) &gt; 3 X ULN , OR If neonate , absence intentional anticoagulation , INR &gt; 1.5 X ULN PT &gt; 1.5 X ULN Subject significantly impair renal function know significant renal disease opinion Investigator would contraindicate study participation . Subject nursing assessment document moderate severe pain ( pain intensity score least 4 LNPS FLACC ) within 6 hour prior randomization Subject require least one dose parenteral opioid medication pain management ( i.e. , preemptive therapy ) 6hour prerandomization period , anticipated require least one dose parenteral opioid medication 24 hour treatment period If subject breast feeding , mother administer acetaminophen contain product previous 6 hour T0 throughout treatment period</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>2 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Moderate severe acute pain follow surgery trauma</keyword>
</DOC>